We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Show more
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced the appointment of...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase 9,000...
-- STAR-0215 Dosed Once or Twice Over 6 Months Reduced Monthly Attack Rates by 90-96%, Supporting Chronic Dosing 2 or 4 Times Per Year -- -- 92-100% Decrease in Moderate or Severe Attacks and...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase...
-- ALPHA-STAR Trial of STAR-0215 Initial Proof-of-Concept Data in HAE Patients Expected Q1 2024 -- -- STAR-0310, Potential Best-in-Class OX40 Program for the Treatment of Atopic Dermatitis, on...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.42 | -13.6276391555 | 10.42 | 10.64 | 8.81 | 1098028 | 9.52030648 | CS |
| 4 | -5.22 | -36.7088607595 | 14.22 | 14.22 | 8.81 | 846504 | 10.89748586 | CS |
| 12 | -4.32 | -32.4324324324 | 13.32 | 16.9 | 8.81 | 1022365 | 13.67511993 | CS |
| 26 | 4.33 | 92.7194860814 | 4.67 | 16.9 | 4.26 | 793820 | 11.25543471 | CS |
| 52 | -2.72 | -23.2081911263 | 11.72 | 16.9 | 4.26 | 500958 | 10.81948827 | CS |
| 156 | 0.47 | 5.50996483001 | 8.53 | 16.9 | 2.36 | 265274 | 10.46545923 | CS |
| 260 | 0.47 | 5.50996483001 | 8.53 | 16.9 | 2.36 | 265274 | 10.46545923 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
